dc.contributor.author | Aydin, HI | |
dc.contributor.author | Ulucan, H | |
dc.contributor.author | Baltaci, V | |
dc.contributor.author | Denli, M | |
dc.contributor.author | Karapinar, K | |
dc.contributor.author | Dundaroz, R | |
dc.date.accessioned | 2021-03-05T07:34:31Z | |
dc.date.available | 2021-03-05T07:34:31Z | |
dc.date.issued | 2001 | |
dc.identifier.citation | Dundaroz R., Ulucan H., Denli M., Karapinar K., Aydin H., Baltaci V., "Evaluation of DNA damage using the comet assay in children on long-term benzathine penicillin for secondary prophylaxis of rheumatic fever", PEDIATRICS INTERNATIONAL, cilt.43, ss.276-280, 2001 | |
dc.identifier.issn | 1328-8067 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_947aaa71-b509-45fa-a29a-d0f1a0343491 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/100014 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/pubmed/11380924 | |
dc.identifier.uri | https://doi.org/10.1046/j.1442-200x.2001.01397.x | |
dc.description.abstract | Backround: Benzathine penicillin is the most widely used antibiotic in the prophylaxis of children with rheumatic fever. The aim of the present study was to evaluate the DNA damage in children receiving one dose of 1.2 million units benzathine penicillin every 4 weeks over a long period to prevent recurrences of rheumatic fever. | |
dc.language.iso | eng | |
dc.subject | Klinik Tıp | |
dc.subject | Çocuk Sağlığı ve Hastalıkları | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | PEDİATRİ | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.title | Evaluation of DNA damage using the comet assay in children on long-term benzathine penicillin for secondary prophylaxis of rheumatic fever | |
dc.type | Makale | |
dc.relation.journal | PEDIATRICS INTERNATIONAL | |
dc.contributor.department | , , | |
dc.identifier.volume | 43 | |
dc.identifier.issue | 3 | |
dc.identifier.startpage | 276 | |
dc.identifier.endpage | 280 | |
dc.contributor.firstauthorID | 727744 | |